Mallinckrodt, Craig H: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder

Stephen K. Brannan, Craig H. Mallinckrodt, Eileen B. Brown, Madelaine M. Wohlreich, John G. Watkin, Alan F. Schatzberg

Journal:

Journal of Psychiatric Research

Year:

2005

Language:

english

File:

PDF, 228 KB

english, 2005

2

Differential Antidepressant Symptom Efficacy: Placebo-Controlled Comparisons of Duloxetine and SSRIs (Fluoxetine, Paroxetine, Escitalopram)

Mallinckrodt, Craig H., Prakash, Apurva, Houston, John P., Swindle, Ralph, Detke, Michael J., Fava, Maurizio

Journal:

Neuropsychobiology

Year:

2007

Language:

english

File:

PDF, 336 KB

english, 2007

3

Duloxetine for the treatment of major depressive disorder: A closer look at efficacy and safety data across the approved dose range

Craig H. Mallinckrodt, Apurva Prakash, Anne C. Andorn, John G. Watkin, Madelaine M. Wohlreich

Journal:

Journal of Psychiatric Research

Year:

2006

Language:

english

File:

PDF, 180 KB

english, 2006

4

Choosing estimands in clinical trials with missing data

Mallinckrodt, Craig, Molenberghs, Geert, Rathmann, Suchitrita

Journal:

Pharmaceutical Statistics

Year:

2016

Language:

english

File:

PDF, 162 KB

english, 2016

5

Evaluation of sPGAxBSA as an outcome measure and treatment target for clinical practice

Merola, Joseph F., Amato, David A., See, Kyoungah, Burge, Russel, Mallinckrodt, Craig, Ojeh, Clement K., Gottlieb, Alice

Journal:

The Journal of Investigative Dermatology

Year:

2018

Language:

english

File:

PDF, 2.82 MB

english, 2018

6

Causal inference and estimands in clinical trials

Lipkovich, Ilya, Ratitch, Bohdana, Mallinckrodt, Craig H

Journal:

Statistics in Biopharmaceutical Research

Year:

2019

File:

PDF, 785 KB

2019

7

Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression

Shelton, Richard C., Andorn, Anne C., Mallinckrodt, Craig H., Wohlreich, Madelaine M., Raskin, Joel, Watkin, John G., Detke, Michael J.

Journal:

International Clinical Psychopharmacology

Year:

2007

Language:

english

File:

PDF, 182 KB

english, 2007

8

Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) Guidelines

Ratitch, Bohdana, Goel, Niti, Mallinckrodt, Craig, Bell, James, Bartlett, Jonathan W., Molenberghs, Geert, Singh, Pritibha, Lipkovich, Ilya, O’Kelly, Michael

Journal:

Therapeutic Innovation & Regulatory Science

Year:

2019

Language:

english

File:

PDF, 317 KB

english, 2019

9

Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice

Ratitch, Bohdana, Bell, James, Mallinckrodt, Craig, Bartlett, Jonathan W., Goel, Niti, Molenberghs, Geert, O’Kelly, Michael, Singh, Pritibha, Lipkovich, Ilya

Journal:

Therapeutic Innovation & Regulatory Science

Year:

2020

File:

PDF, 407 KB

2020

10

Duloxetine in the treatment of major depressive disorder: Comparisons of safety and tolerability in male and female patients

Donna E. Stewart, Madelaine M. Wohlreich, Craig H. Mallinckrodt, John G. Watkin, Susan G. Kornstein

Journal:

Journal of Affective Disorders

Year:

2006

Language:

english

File:

PDF, 116 KB

english, 2006

11

The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials

Craig H Mallinckrodt, Joel Raskin, Madelaine M Wohlreich, John G Watkin, Michael J Detke

Journal:

Year:

2004

Language:

english

File:

PDF, 522 KB

english, 2004

12

Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine

John Greist, Robert K. McNamara, Craig H. Mallinckrodt, Jyoti N. Rayamajhi, Joel Raskin

Journal:

Clinical Therapeutics

Year:

2004

Language:

english

File:

PDF, 844 KB

english, 2004

13

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study*

Nierenberg, Andrew A., Greist, John H., Mallinckrodt, Craig H., Prakash, Apurva, Sambunaris, Angelo, Tollefson, Gary D., Wohlreich, Madelaine M.

Journal:

Current Medical Research and Opinion

Year:

2007

Language:

english

File:

PDF, 546 KB

english, 2007

14

ACCOUNTING FOR DROPOUT BIAS USING MIXED-EFFECTS MODELS

Mallinckrodt, Craig H., Clark, W. Scott, David, Stacy R.

Journal:

Journal of Biopharmaceutical Statistics

Year:

2001

Language:

english

File:

PDF, 139 KB

english, 2001

15

Missing Data: Turning Guidance Into Action

Mallinckrodt, Craig, Roger, James, Chuang-stein, Christy, Molenberghs, Geert, Lane, Peter W., O’kelly, Michael, Ratitch, Bohdana, Xu, Lei, Gilbert, Steve, Mehrotra, Devan V., Wolfinger, Russ, Thijs, H

Journal:

Statistics in Biopharmaceutical Research

Year:

2013

Language:

english

File:

PDF, 316 KB

english, 2013

16

A Comparison of Sevoflurane and Isoflurane for Short-Term Anesthesia in Polecats (Mustela eversmanni)

James S. Gaynor, Jeffrey Wimsatt, Craig Mallinckrodt and Dean Biggins

Journal:

Journal of Zoo and Wildlife Medicine

Year:

1997

Language:

english

File:

PDF, 1022 KB

english, 1997

17

Nonparametric covariate adjustment in estimating hazard ratios

Jiang, Honghua, Kulkarni, Pandurang M, Wang, Yanping, Mallinckrodt, Craig H

Journal:

Pharmaceutical Statistics

Year:

2016

Language:

english

File:

PDF, 177 KB

english, 2016

18

To adjust or not to adjust for baseline when analyzing repeated binary responses? The case of complete data when treatment comparison at study end is of interest

Jiang, Honghua, Kulkarni, Pandurang M., Mallinckrodt, Craig H., Shurzinske, Linda, Molenberghs, Geert, Lipkovich, Ilya

Journal:

Pharmaceutical Statistics

Year:

2015

Language:

english

File:

PDF, 722 KB

english, 2015

19

Covariate Adjustment for Logistic Regression Analysis of Binary Clinical Trial Data

Jiang, Honghua, Kulkarni, Pandurang M, Mallinckrodt, Craig H, Shurzinske, Linda, Molenberghs, Geert, Lipkovich, Ilya

Journal:

Statistics in Biopharmaceutical Research

Year:

2016

Language:

english

File:

PDF, 786 KB

english, 2016

20

Points to consider for analyzing efficacy outcomes in long-term extension clinical trials

Ratitch, Bohdana, Lipkovich, Ilya, Erickson, Janelle Shannon, Zhang, Lu, Mallinckrodt, Craig H.

Journal:

Pharmaceutical Statistics

Year:

2018

Language:

english

File:

PDF, 586 KB

english, 2018

21

Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) Guidelines

Ratitch, Bohdana, Goel, Niti, Mallinckrodt, Craig, Bell, James, Bartlett, Jonathan W., Molenberghs, Geert, Singh, Pritibha, Lipkovich, Ilya, O’Kelly, Michael

Journal:

Therapeutic Innovation & Regulatory Science

Year:

2019

File:

PDF, 317 KB

2019

22

Preventing and Treating Missing Data in Longitudinal Clinical Trials (A Practical Guide) || Methods of Dealing with Missing Data

Mallinckrodt, Craig

Year:

2013

Language:

english

File:

PDF, 99 KB

english, 2013

23

Preventing and Treating Missing Data in Longitudinal Clinical Trials (A Practical Guide) || Example

Mallinckrodt, Craig

Year:

2013

Language:

english

File:

PDF, 149 KB

english, 2013

24

Preventing and Treating Missing Data in Longitudinal Clinical Trials (A Practical Guide) || Trial Conduct Considerations

Mallinckrodt, Craig

Year:

2013

Language:

english

File:

PDF, 46 KB

english, 2013

25

Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma : A double-blind, randomized placebo-controlled study

Gregory K. Ogilvie, Martin J. Fettman, Craig H. Mallinckrodt, Judy A. Walton, Rodney A. Hansen, Deborah J. Davenport, Kathy L. Gross, Kristi L. Richardson, Quinton Rogers, Michael S. Hand

Journal:

Year:

2000

Language:

english

File:

PDF, 180 KB

english, 2000

26

Duloxetine in treatment of anxiety symptoms associated with depression

David L. Dunner, David J. Goldstein, Craig Mallinckrodt, Yili Lu, Michael J. Detke

Journal:

Depression and Anxiety

Year:

2003

Language:

english

File:

PDF, 119 KB

english, 2003

27

Time course of depression-symptom improvement during treatment with duloxetine

Robert M.A. Hirschfeld, Craig Mallinckrodt, Thomas C. Lee, Michael J. Detke

Journal:

Depression and Anxiety

Year:

2005

Language:

english

File:

PDF, 148 KB

english, 2005

28

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation

Madelaine M. Wohlreich, Craig H. Mallinckrodt, Apurva Prakash, John G. Watkin, William P. Carter

Journal:

Depression and Anxiety

Year:

2007

Language:

english

File:

PDF, 283 KB

english, 2007

29

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

James I. Hudson, Madelaine M. Wohlreich, Daniel K. Kajdasz, Craig H. Mallinckrodt, John G. Watkin, Oleg V. Martynov

Journal:

Human Psychopharmacology: Clinical and Experimental

Year:

2005

Language:

english

File:

PDF, 185 KB

english, 2005

30

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study

Madelaine M Wohlreich, Craig H Mallinckrodt, John G Watkin, Donald P Hay

Journal:

Year:

2004

Language:

english

File:

PDF, 545 KB

english, 2004

31

Evaluating dose response from flexible dose clinical trials

Ilya Lipkovich, David H Adams, Craig Mallinckrodt, Doug Faries, David Baron, John P Houston

Journal:

Year:

2008

Language:

english

File:

PDF, 231 KB

english, 2008

32

Type I error rates from likelihood-based repeated measures analyses of incomplete longitudinal data

Craig H. Mallinckrodt, Christopher J. Kaiser, John G. Watkin, Michael J. Detke, Geert Molenberghs, Raymond J. Carroll

Journal:

Pharmaceutical Statistics

Year:

2004

Language:

english

File:

PDF, 239 KB

english, 2004

33

Choice of the primary analysis in longitudinal clinical trials

Craig H. Mallinckrodt, John G. Watkin, Geert Molenberghs, Raymond J. Carroll

Journal:

Pharmaceutical Statistics

Year:

2004

Language:

english

File:

PDF, 166 KB

english, 2004

34

A case study comparing a randomized withdrawal trial and a double-blind long-term trial for assessing the long-term efficacy of an antidepressant

Craig Mallinckrodt, Christy Chuang-Stein, Paul McSorley, Jeffrey Schwartz, Donald G. Archibald, David G. Perahia, Michael J. Detke, Larry Alphs

Journal:

Pharmaceutical Statistics

Year:

2007

Language:

english

File:

PDF, 248 KB

english, 2007

35

The test of public scrutiny

Craig H. Mallinckrodt

Journal:

Pharmaceutical Statistics

Year:

2006

Language:

english

File:

PDF, 110 KB

english, 2006

36

The impact of missing data and how it is handled on the rate of false-positive results in drug development

Sunni A. Barnes, Craig H. Mallinckrodt, Stacy R. Lindborg, M. Kallin Carter

Journal:

Pharmaceutical Statistics

Year:

2008

Language:

english

File:

PDF, 205 KB

english, 2008

37

Comparing onset of antidepressant action using a repeated measures approach and a traditional assessment schedule

Craig H. Mallinckrodt, Michael J. Detke, Christopher J. Kaiser, John G. Watkin, Geert Molenberghs, Raymond J. Carroll

Journal:

Statistics in Medicine

Year:

2006

Language:

english

File:

PDF, 116 KB

english, 2006

38

A Latent-Class Mixture Model for Incomplete Longitudinal Gaussian Data

Caroline Beunckens, Geert Molenberghs, Geert Verbeke, Craig Mallinckrodt

Journal:

Year:

2008

Language:

english

File:

PDF, 208 KB

english, 2008

39

10.1038/35088122

Rubin, Clinton, Turner, A. Simon, Bain, Steven, Mallinckrodt, Craig, McLeod, Kenneth

Journal:

Year:

2001

Language:

english

File:

PDF, 131 KB

english, 2001

40

The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder*

Sheehan, David V., Meyers, Adam L., Prakash, Apurva, Robinson, Michael J., Swindle, Ralph W., Russell, James M., Mallinckrodt, Craig H.

Journal:

Current Medical Research and Opinion

Year:

2008

Language:

english

File:

PDF, 159 KB

english, 2008

41

Does Pain Mediate the Pain Interference with Sleep Problem in Chronic Pain? Findings from Studies for Management of Diabetic Peripheral Neuropathic Pain with Duloxetine

David A. Fishbain, Jerry Hall, Adam L. Meyers, Jill Gonzales, Craig Mallinckrodt

Journal:

Journal of Pain and Symptom Management

Year:

2008

Language:

english

File:

PDF, 258 KB

english, 2008

42

Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies

Stephen K. Brannan, Craig H. Mallinckrodt, Michael J. Detke, John G. Watkin, Gary D. Tollefson

Journal:

Journal of Psychiatric Research

Year:

2005

Language:

english

File:

PDF, 259 KB

english, 2005

43

Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales

Annouschka Laenen, Ariel Alonso, Geert Molenberghs, Tony Vangeneugden, Craig H. Mallinckrodt

Journal:

Journal of Psychiatric Research

Year:

2009

Language:

english

File:

PDF, 361 KB

english, 2009

44

Recent developments in improving signal detection and reducing placebo response in psychiatric clinical trials

Craig H. Mallinckrodt, Roy N. Tamura, Yoko Tanaka

Journal:

Journal of Psychiatric Research

Year:

2011

Language:

english

File:

PDF, 141 KB

english, 2011

45

Utility of positive controls in assessing assay sensitivity in ICH S7B and ICH E14 guidance for evaluation of QT/QTc interval prolongation

Alan Y. Chiang, Craig H. Mallinckrodt, Alex A. Dmitrienko, Derek J. Leishman

Journal:

Journal of Pharmacological and Toxicological Methods

Year:

2010

Language:

english

File:

PDF, 132 KB

english, 2010

46

ORIGINAL RESEARCH—PSYCHOLOGY: Changes in Sexual Functioning Associated with Duloxetine, Escitalopram, and Placebo in the Treatment of Patients with Major Depressive Disorder

Anita Clayton, Susan Kornstein, Apurva Prakash, Craig Mallinckrodt, Madelaine Wohlreich

Journal:

The Journal of Sexual Medicine

Year:

2007

Language:

english

File:

PDF, 294 KB

english, 2007

47

Surgery and Doxorubicin in Dogs With Hemangiosarcoma

Gregory K. Ogilvie, Barbara E. Powers, Craig H. Mallinckrodt, Stephen J. Withrow

Journal:

Journal of Veterinary Internal Medicine

Year:

1996

Language:

english

File:

PDF, 671 KB

english, 1996

48

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features

Craig H Mallinckrodt, John G Watkin, Chaofeng Liu, Madelaine M Wohlreich, Joel Raskin

Journal:

Year:

2005

Language:

english

File:

PDF, 595 KB

english, 2005

49

Clinical consequences of initial duloxetine dosing strategies: Comparison of 30 and 60 mg QD starting doses

David L. Dunner, Madelaine M. Wohlreich, Craig H. Mallinckrodt, John G. Watkin, Maurizio Fava

Journal:

Current Therapeutic Research

Year:

2005

Language:

english

File:

PDF, 1016 KB

english, 2005

50

Duloxetine for the Treatment of Major Depressive Disorder in Women Ages 40 to 55 Years

Vivien K. Burt, Madelaine M. Wohlreich, Craig H. Mallinckrodt, Michael J. Detke, John G. Watkin, Donna E. Stewart

Journal:

Year:

2005

Language:

english

File:

PDF, 187 KB

english, 2005